Showing results (161-170 of 3,633) with videos related to

Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|November 11, 2021
Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patientsMax A A Ragusi, Tycho Bismeijer, Bas H M van der Velden, et al.
Breast (Edinburgh, Scotland)|November 12, 2021
Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancerAurelia Noske, Daniel-Christoph Wagner, Kristina Schwamborn, et al.
Breast (Edinburgh, Scotland)|December 16, 2021
Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening programJing Wang, Marcel J W Greuter, Karin M Vermeulen, et al.
Breast (Edinburgh, Scotland)|October 9, 2022
Adjuvant endocrine therapy in patients with estrogen receptor-low positive breast cancer: A prospective cohort studyYuxin Xie, Libo Yang, Yanqi Wu, et al.
Breast (Edinburgh, Scotland)|October 8, 2022
Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter studyHasan Çağrı Yıldırım, Emel Mutlu, Elvin Chalabiyev, et al.
Breast (Edinburgh, Scotland)|September 9, 2022
Current and future burden of breast cancer: Global statistics for 2020 and 2040Melina Arnold, Eileen Morgan, Harriet Rumgay, et al.
Breast (Edinburgh, Scotland)|September 9, 2022
Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysisYinggang Xu, Weiwei Zhang, Jinzhi He, et al.
Breast (Edinburgh, Scotland)|November 4, 2021
Genetic heterogeneity during breast cancer progression in young patientsKanako Hagio, Kanako C Hatanaka, Toraji Amano, et al.
Breast (Edinburgh, Scotland)|January 7, 2022
Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, ChinaYiqun Li, Hongnan Mo, Xiuwen Guan, et al.
Breast (Edinburgh, Scotland)|October 21, 2022
Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancerXu-Ran Zhao, Yu Tang, Hong-Fen Wu, et al.
Pageof 364